{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:16:36Z","timestamp":1784978196439,"version":"3.55.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"European Union, Interreg V \u00d6KS, and Ferring Pharmaceuticals"},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,28]]},"abstract":"Abstract<\/jats:title>STUDY QUESTION<\/jats:title>Does letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF reduce the proportion of women with premature progesterone levels above 1.5 ng\/ml at the time of triggering final oocyte maturation?<\/jats:p><\/jats:sec>SUMMARY ANSWER<\/jats:title>The proportion of women with premature progesterone above 1.5 ng\/ml was not significantly affected by letrozole co-treatment.<\/jats:p><\/jats:sec>WHAT IS KNOWN ALREADY<\/jats:title>IVF creates multiple follicles with supraphysiological levels of sex steroids interrupting the endocrine milieu and affects the window of implantation. Letrozole is an effective aromatase inhibitor, normalizing serum oestradiol, thereby ameliorating some of the detrimental effects of IVF treatment.<\/jats:p><\/jats:sec>STUDY DESIGN, SIZE, DURATION<\/jats:title>A randomized, double-blinded placebo-controlled trial investigated letrozole intervention during stimulation for IVF with FSH. The trial was conducted at four fertility clinics at University Hospitals in Denmark from August 2016 to November 2018.<\/jats:p><\/jats:sec>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>A cohort of 129 women with expected normal ovarian reserve (anti-M\u00fcllerian hormone 8\u201332 nmol\/l) completed an IVF cycle with fresh embryo transfer and received co-treatment with either 5 mg\/day letrozole (n = 67) or placebo (n = 62), along with the FSH. Progesterone, oestradiol, FSH, LH and androgens were analysed in repeated serum samples collected from the start of the stimulation to the mid-luteal phase. In addition, the effect of letrozole on reproductive outcomes, total FSH consumption and adverse events were assessed.<\/jats:p><\/jats:sec>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>The proportion of women with premature progesterone &gt;1.5 ng\/ml was similar (6% vs 0% (OR 0.0, 95% CI [0.0; 1.6], P = 0.12) in the letrozole versus placebo groups, respectively), whereas the proportion of women with mid-luteal progesterone &gt;30 ng\/ml was significantly increased in the letrozole group: (59% vs 31% (OR 3.3, 95% CI [1.4; 7.1], P = 0.005)). Letrozole versus placebo decreased oestradiol levels on the ovulation trigger day by 68% (95% CI [60%; 75%], P &lt; 0.0001). Other hormonal profiles, measured as AUC, showed the following results. The increase in LH in the letrozole group versus placebo group was 38% (95% CI [21%; 58%], P &lt; 0.0001) and 34% (95% CI [11%; 61%], P = 0.006) in the follicular and luteal phases, respectively. In the letrozole group versus placebo group, testosterone increased by 79% (95% CI [55%; 105%], P &lt; 0.0001) and 49% (95% CI [30%; 72%], P &lt; 0.0001) in the follicular and luteal phases, respectively. In the letrozole group versus placebo group, the increase in androstenedione was by 85% (95% CI [59%; 114%], P &lt; 0.0001) and 69% (95% CI [48%; 94%], P &lt; 0.0001) in the follicular and luteal phases, respectively. The ongoing pregnancy rate was similar between the letrozole and placebo groups (31% vs 39% (risk-difference of 8%, 95% CI [\u221225%; 11%], P = 0.55)). No serious adverse reactions were recorded in either group. The total duration of exogenous FSH stimulation was 1 day shorter in the intervention group, significantly reducing total FSH consumption (mean difference \u2212100 IU, 95% CI [\u2212192; \u221221], P = 0.03).<\/jats:p><\/jats:sec>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>Late follicular progesterone samples were collected on the day before and day of ovulation triggering for patient logistic considerations, and the recently emerged knowledge about diurnal variation of progesterone was not taken into account. The study was powered to detect hormonal variations but not differences in pregnancy outcomes.<\/jats:p><\/jats:sec>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>Although the use of letrozole has no effect on the primary outcome, the number of women with a premature increase in progesterone on the day of ovulation triggering, the increased progesterone in the mid-luteal phase due to letrozole may contribute to optimizing the luteal phase endocrinology. The effect of letrozole on increasing androgens and reducing FSH consumption may be used in poor responders. However, the effect of letrozole on implantation and ongoing pregnancy rates should be evaluated in a meta-analysis or larger randomized controlled trial (RCT).<\/jats:p><\/jats:sec>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>Funding was received from EU Interreg for ReproUnion and Ferring Pharmaceuticals, and Roche Diagnostics contributed with assays. N.S.M. and A.P. have received grants from Ferring, Merck Serono, Anecova and Gedeon Richter, and\/or personal fees from IBSA, Vivoplex, ArtPred and SPD, outside the submitted work. The remaining authors have no competing interests.<\/jats:p><\/jats:sec>TRIAL REGISTRATION NUMBERS<\/jats:title>NCT02939898 and NCT02946684<\/jats:p><\/jats:sec>TRIAL REGISTRATION DATE<\/jats:title>15 August 2016.<\/jats:p><\/jats:sec>DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title>22 August 2016.<\/jats:p><\/jats:sec>","DOI":"10.1093\/humrep\/deab249","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T19:13:13Z","timestamp":1635361993000},"page":"309-321","source":"Crossref","is-referenced-by-count":34,"title":["Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2005-7277","authenticated-orcid":false,"given":"Nathalie S\u00f8derhamn","family":"B\u00fclow","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital, Herlev, Copenhagen, Denmark"},{"name":"The Fertility Department, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Olaf","family":"Skouby","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital, Herlev, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka Katarzyna","family":"Warzecha","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital, Herlev, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Udengaard","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital, Herlev, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Yding","family":"Andersen","sequence":"additional","affiliation":[{"name":"Laboratory of Reproductive Biology, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Dreyer","family":"Holt","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Zealand University Hospital, K\u00f8ge, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8339-4786","authenticated-orcid":false,"given":"Marie Louise","family":"Gr\u00f8ndahl","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital, Herlev, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Nyboe Andersen","sequence":"additional","affiliation":[{"name":"The Fertility Department, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negjyp","family":"Sopa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lis Englund","family":"Mikkelsen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Zealand University Hospital, K\u00f8ge, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-104X","authenticated-orcid":false,"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[{"name":"The Fertility Department, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Stephen","family":"Macklon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Zealand University Hospital, K\u00f8ge, Denmark"},{"name":"London Women's Clinic, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"2022020106053437400_deab249-B1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/molehr\/gaw070","article-title":"Inhibin-B secretion and FSH isoform distribution may play an integral part of follicular selection in the natural menstrual cycle","volume":"23","author":"Andersen","year":"2017","journal-title":"Mol Hum Reprod"},{"key":"2022020106053437400_deab249-B2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.rbmo.2014.01.012","article-title":"Improving the luteal phase after ovarian stimulation: reviewing new options","volume":"28","author":"Andersen","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2022020106053437400_deab249-B3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.fertnstert.2020.05.022","article-title":"Shortcomings of an unphysiological triggering of oocyte maturation using human chorionic gonadotropin","volume":"114","author":"Andersen","year":"2020","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10815-006-9101-x","article-title":"Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation","volume":"24","author":"Arslan","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"2022020106053437400_deab249-B5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022020106053437400_deab249-B6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/uog.17442","article-title":"Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis","volume":"50","author":"Bechtejew","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2022020106053437400_deab249-B7","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","article-title":"Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2022020106053437400_deab249-B8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B"},{"key":"2022020106053437400_deab249-B9","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.fertnstert.2005.07.230","article-title":"The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins","volume":"84","author":"Biljan","year":"2005","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B1001","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/deq125","article-title":"Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: Analysis of over 4000 cycles","volume":"25","author":"Bosch","year":"2010","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B10","first-page":"1444","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"FNS"},{"key":"2022020106053437400_deab249-B11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/humrep\/dey388","article-title":"Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis","volume":"34","author":"Bosdou","year":"2019","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B12","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.10908","article-title":"An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane","volume":"95","author":"Buzdar","year":"2002","journal-title":"Cancer"},{"key":"2022020106053437400_deab249-B13","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.fertnstert.2012.10.008","article-title":"A historical perspective of aromatase inhibitors for ovulation induction","volume":"98","author":"Casper","year":"2012","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B1002","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0015-0282(00)01789-1","article-title":"Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran\/Antagon)","volume":"75","author":"de","year":"2001","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/09513590.2015.1110133","article-title":"Controlled ovarian hyperstimulation with sequential letrozole co-treatment in normo\/high responders","volume":"32","author":"Ecemis","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2022020106053437400_deab249-B15","first-page":"287","article-title":"Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: an RCT Running","volume":"18","author":"Eftekhar","year":"2020","journal-title":"Int J Reprod Biomed"},{"key":"2022020106053437400_deab249-B16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.rbmo.2010.05.018","article-title":"The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles","volume":"21","author":"Fleming","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2022020106053437400_deab249-B17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1701-2163(16)32551-8","article-title":"Fetal safety of letrozole and clomiphene citrate for ovulation induction","volume":"29","author":"Forman","year":"2007","journal-title":"J Obstetr Gynaecol Can"},{"key":"2022020106053437400_deab249-B18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B1003","first-page":"222","article-title":"Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: A randomized, placebo-controlled trial","volume":"92","author":"Garcia-Velasco","year":"2009","journal-title":"FNS"},{"key":"2022020106053437400_deab249-B19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/humrep\/dez091","article-title":"Clinically significant intra-day variability of serum progesterone levels during the final day of oocyte maturation: a prospective study with repeated measurements","volume":"34","author":"Gonz\u00e1lez-Foruria","year":"2019","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.fertnstert.2018.02.009","article-title":"Introduction","volume":"109","author":"Griesinger","year":"2018","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12958-017-0288-8","article-title":"Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?","volume":"15","author":"Haas","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"2022020106053437400_deab249-B22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.fertnstert.2017.08.017","article-title":"In vitro fertilization treatments with the use of clomiphene citrateor letrozole","volume":"108","author":"Haas","year":"2017","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B23","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2022020106053437400_deab249-B1004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/19396368.2014.957879","article-title":"Effects of different doses of letrozole on the incidence of early-onset ovarian hyperstimulation syndrome after oocyte retrieval","volume":"60","author":"He","year":"2014","journal-title":"Syst Biol Reprod Med"},{"key":"2022020106053437400_deab249-B24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2020.23718","article-title":"Association of fresh embryo transfers compared with cryopreserved-thawed embryo transfers with live birth rate among women undergoing assisted reproduction using freshly retrieved donor oocytes","volume":"325","author":"Insogna","year":"2021","journal-title":"JAMA"},{"key":"2022020106053437400_deab249-B25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.fertnstert.2004.01.027","article-title":"Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists","volume":"82","author":"Kolibianakis","year":"2004","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejogrb.2012.02.025","article-title":"The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist\/recombinant FSH-stimulated cycles","volume":"162","author":"Kyrou","year":"2012","journal-title":"Eur J Obstetr Gynecol Reprod Biol"},{"key":"2022020106053437400_deab249-B27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.rbmo.2011.05.012","article-title":"Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial","volume":"23","author":"Lee","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"2022020106053437400_deab249-B28","doi-asserted-by":"crossref","first-page":"433.e1","DOI":"10.1016\/j.ajog.2017.12.223","article-title":"Effect of frozen\/thawed embryo transfer on birthweight, macrosomia, and low birthweight rates in US singleton infants","volume":"218","author":"Litzky","year":"2018","journal-title":"Am J Obstetr Gynecol"},{"key":"2022020106053437400_deab249-B29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fendo.2020.00627","article-title":"Biological and clinical rationale for androgen priming in ovarian stimulation","volume":"11","author":"Lossl","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022020106053437400_deab249-B30","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1073\/pnas.0530162100","article-title":"Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation","volume":"100","author":"Ma","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020106053437400_deab249-B31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"2022020106053437400_deab249-B32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/humupd\/dmx031","article-title":"Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?","volume":"24","author":"Maheshwari","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2022020106053437400_deab249-B33","first-page":"305","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"FNS"},{"key":"2022020106053437400_deab249-B34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jsgi.2004.03.006","article-title":"Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation","volume":"11","author":"Mitwally","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"2022020106053437400_deab249-B35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7827-3-54","article-title":"The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment","volume":"3","author":"Mitwally","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"2022020106053437400_deab249-B36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"2022020106053437400_deab249-B37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.rbmo.2009.05.007","article-title":"Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols","volume":"19","author":"Ozmen","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2022020106053437400_deab249-B38","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.fertnstert.2006.12.064","article-title":"Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer","volume":"91","author":"Papanikolaou","year":"2009","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B39","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/humrep\/des066","article-title":"GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study","volume":"27","author":"Papanikolaou","year":"2012","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B40","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2012.09.022","article-title":"Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer","volume":"98","author":"Reddy","year":"2012","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod (Oxford, England)"},{"key":"2022020106053437400_deab249-B42","author":"Schulz","year":"2010"},{"key":"2022020106053437400_deab249-B43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.05.050","article-title":"Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders","volume":"96","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B44","doi-asserted-by":"crossref","first-page":"e108219","DOI":"10.1371\/journal.pone.0108219","article-title":"Congenital malformations among babies born following letrozole or clomiphene for infertility treatment","volume":"9","author":"Sharma","year":"2014","journal-title":"PloS One"},{"key":"2022020106053437400_deab249-B45","doi-asserted-by":"crossref","first-page":"m2519","DOI":"10.1136\/bmj.m2519","article-title":"Freeze-all versus fresh blastocyst transfer strategy during in vitro fertilisation in women with regular menstrual cycles: multicentre randomised controlled trial","volume":"370","author":"Stormlund","year":"2020","journal-title":"BMJ"},{"key":"2022020106053437400_deab249-B46","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendation from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B47","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B48","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/oxfordjournals.humrep.a019409","article-title":"Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles","volume":"11","author":"Ubaldi","year":"1996","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rbmo.2010.11.002","article-title":"Progesterone rise on HCG day in GnRH antagonist\/rFSH stimulated cycles affects endometrial gene expression","volume":"22","author":"Van Vaerenbergh","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"2022020106053437400_deab249-B50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/humrep\/deu362","article-title":"Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles","volume":"30","author":"Venetis","year":"2015","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/humupd\/dmt014","article-title":"Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles","volume":"19","author":"Venetis","year":"2013","journal-title":"Hum Reprod Update"},{"key":"2022020106053437400_deab249-B52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1472-6483(10)60611-6","article-title":"Aromatase inhibitors in ovarian stimulation for IVF\/ICSI: a pilot study","volume":"13","author":"Verpoest","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2022020106053437400_deab249-B53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.fertnstert.2017.05.007","article-title":"Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates","volume":"108","author":"Wang","year":"2017","journal-title":"Fertil Steril"},{"key":"2022020106053437400_deab249-B54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13048-015-0190-y","article-title":"Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?","volume":"8","author":"Wang","year":"2015","journal-title":"J Ovarian Res"},{"key":"2022020106053437400_deab249-B55","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2022020106053437400_deab249-B56","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1093\/humrep\/det272","article-title":"Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic Cohort study from the CoNARTaS group","volume":"28","author":"Wennerholm","year":"2013","journal-title":"Hum Reprod"},{"key":"2022020106053437400_deab249-B57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12958-019-0483-x","article-title":"Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study","volume":"17","author":"Yang","year":"2019","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/2\/309\/42324384\/deab249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/2\/309\/42324384\/deab249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T22:25:41Z","timestamp":1726007141000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/2\/309\/6430925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,11,18]]},"published-print":{"date-parts":[[2022,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deab249","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,11,18]]}}}